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Mesangial cell actin disassembly in high glucose mediated by protein
kinase C and the polyol pathway. High glucose alters mesangial cell
cytoskeletal structure and function. We postulated that high glucose
causes mesangial cell filamentous (F) actin disassembly through a protein
kinase C (PKC) mechanism involving the polyol pathway. Rat mesangial
cells (passage < 10, N = 60/group) were growth-arrested and then
cultured in glucose 5.6 mi (NG), 15 mtvt (MG) or 30 mai (HG) for 48
hours, with or without the aldose reductasc inhibitor Tolrestat 0.3 mai. F
and globular (G) actin were labeled with rhodamine-phafloidin and
FITC-DNase-I, respectively. Both fluorescence probes were imaged simul-
taneously in each cell using dual-channel confocal laser microscopy. In
HG, F-actin disassembly was observed and measured by a 40% decrease
in F-/G-actin fluorescence intensity ratio (no change in NG + mannitol
24.4 mM). In separate experiments, cells were labeled with BODIPY
FL-bisindolylmaleimide, specific for most PKC isoforms, and fluorescence
intensity/cell was measured. In NG, exposure to phorbol 12-myristate
13-acetate (PMA) 0.1 jrM for 15 minutes caused perinuclear and nuclear
translocation of PKC, and F-actin disassembly identical to observations in
HG alone. In HG, total PKC fluorescence increased by 50% and PMA
exposure for 24 hours normalized both the total PKC and F-/G-actin
fluorescence ratio. In NG and HG, exposure (15 mm) to PMA 0.1 fLM
increased PKC activity three to four times, measured by in situ 32P-
phosphorylation of EGF-receptor substrate. By immunofluorecence and
confocal imaging, diacylglycerol-sensitive PKC-8 was localized to the
cytosol in NG, and after 15 minutes exposure to PMA, translocated to the
perinuclear region and plasma membrane, In HG, PKC-b immunofluo-
rescence was significantly increased/cell, distributed in a cytoskeletal
pattern and the intensity was glucose-concentration dependent (30> 15 >
5.6 mM). In HG, exposure to PMA for 24 hours returned the PKC-b
fluorescence to the intensity and cytosolic pattern observed in NG, and
simultaneously prevented F-actin disassembly. Tolrestat significantly re-
duced the total PKC and PKC-8 fluorescence intensity and F-actin
disassembly observed in HG. Immunoblot confirmed increased PKC-8 in
HG, which was normalized by Tolrestat. The immunofluorescence pattern
of diacylglycerol-insensitive PKC- was unchanged in HG, with PMA or
Tolrestat. We conclude that mesangial cell F-actin disassembly in high
glucose is likely mediated through diacylglycerol-sensitive PKC isoforms,
including PKC-b, and involves the polyol pathway.
Diabetes complications arise when the phenotypic characteris-
tics of non-insulin dependent cells are altered in the presence of
high glucose. Through multiple effector mechanisms involving
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intermediate glucose metabolism, high glucose modifies target
cell signaling and gene expression. Previous reports indicated that
within hours of exposure to high glucose, mesangial cells demon-
strate activation of protein kinase C (PKC) [1, 2]. In vivo,
enhanced expression of the protooncogene c-fos is observed in
glomeruli isolated from Streptozotocin (STZ) rats rendered hy-
perglycemic for 12 hours [3]. Secondary effects of high glucose
through autocrine and paracrine growth factors are critically
important in the long-term pathogenesis of progressive diabetic
glomerulosclerosis [4, 5]. In high glucose, enhanced synthesis of
transforming growth factor (TGF)-131 and subsequent autocrine
stimulation of extracellular matrix protein synthesis, such as
collagen IV, by mesangial cells requires days in culture [6] and
weeks in vivo [7]. Recently, we reported that high glucose causes
partial disassembly and depolymerization of filamentous (F) actin
in glomerular mesangial and epithelial cells in primary culture,
and in the cells of glomeruli isolated from the STZ diabetic rat [8].
This cytoskeletal response requires 48 hours of exposure to high
glucose and is reversed in the presence of staurosporine, a
nonspecific PKC inhibitor [8].
F-actin assembly plays a key role in the function of most
eukaryotic cells. Many normal functions of mesangial cells includ-
ing contractility [9], attachment [10], and cytoskeletal tensile
resistance to hydrostatic pressure [11, 12] are dependent on the
state of F-actin assembly. Recently, we observed that mesangial
cells cultured in high glucose, and in glomeruli isolated from the
STZ diabetic rat do not contract in response to endothelin-l or to
raised intracellular calcium stimulated by a calcium ionophore
[13]. These data suggest that in high glucose, the contractile
response of mesangial cell cytoskeletal proteins is altered. In vivo,
loss of glomerular afferent arteriolar tone and contractile re
sponse to vasopressor peptides leads to raised intraglomerular
hydrostatic pressure, contributing to progressive glomerulosclero-
sis [14]. Mesangial cells are smooth muscle-like and share the
same vasoactive peptide receptor expression and signaling path-
ways that regulate contractility [15]. The normal cytoskeletal
response to vasopressor peptide stimulation includes calcium-
dependent myosin light chain phosphoiylation and F-actin partial
disassembly [16]. Activated PKC may regulate the cytoskeletal
response at multiple sites including myosin light chain kinase [17]
and myosin light chain [18]. Acute stimulation of cultured mes-
angial cells with a phorbol ester causes F-actin partial disassembly,
increased globular (G) actin and decrease in cell size similar to the
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pattern observed during vasopressor peptide stimulation or fol-
lowing 48 hours of exposure to high glucose [8].
The functional link between high glucose and PKC activation
may be through de novo synthesis of membrane-associated diac-
ylglycerol (DAG) [11. Raised intracellular glucose is metabolized
in part through the polyoi pathway where aldose reductase
converts glucose to sorbitol. When sorbitol is metabolized to
fructose, the NADH/NAD ratio increases [19]. Excess NADH
favors the conversion of the glycolytic intermediate, dihydroxyac-
etone phosphate, to lysophosphatidic acid — phosphatidic acid
DAG [191. Accumulation of DAG in mesangial cells cultured in
high glucose [1] and in glomeruli isolated from the STZ rat [20]
has been documented. Several isoforms of PKC are DAG-
sensitive, including PKC-a, -13, -b and -E [21]. PKC- is expressed
in mesangial cells [22] but is not DAG-sensitive [21]. In mesangial
cells exposed to high glucose, increased translocation and accu-
mulation of PKC-a and PKC- are reported [22]. We [23] and
others [24, 251 have demonstrated that treatment of the STZ
diabetic rat with an aldose reductase inhibitor normalizes afferent
arteriolar and glomerular mesangial cell contractile function in
the presence of high glucose. Therefore, enhanced glucose me-
tabolism through the polyol pathway may cause altered mesangial
cell cytoskeletal contractile function through DAG-sensistive
PKC isoforms.
In this study, we postulated that high glucose causes mesangial
cell F-actin disassembly through a PKC-dependent pathway. The
potential roles of high glucose activation of the poiyoi pathway
and altered PKC function contributing to F-actin disassembly
were explored. The effects of high glucose on F- and G-actin in
primary cultured rat mesangial cells were observed using confocal
laser microscopy. Total PKC and cytoskeletal-associated DAG-
sensitive PKC-b and DAG-insensitive PKC- were labeled with a
specific fluorescence probe or antibody, and analyzed by confocal
laser microscopy. Total cellular PKC-b was analyzed further with
immunoblotting. To determine if changes in F-actin assembly and
PKC accumulation increase with rising glucose concentration,
cells were cultured in glucose 5.6 mai, 15 m and 30 mM. Mannitol
was used as an osmotic control. To identify the action of DAG-
sensitive PKC on F-actin assembly, phorbol ester stimulation (15
mm) of cells in glucose 5.6 m was examined, in high glucose,
chronic exposure to phorbol ester for 24 hours was used to
down-regulate the action of DAG-sensitive PKC on F-actin. The
action of phorbol ester on PKC activity was confirmed by mea-
suring 32P-phosphorylation of the epidermal growth factor (EGF)
receptor substrate in an in situ assay.
Methods
Dulbecco's modified Eagle medium (DMEM), penicillin, strep-
tomycin, fetal bovine serum (FBS) and trypsin were purchased
from GIBCO (Life Technologies, Burlington, ON, Canada). All
other chemicals were purchased from Sigma Chemicals (St. Louis,
MO, USA). Specific fluorescence probes: rhodaminc-phalloidin,
FITC-DNase-1, BODIPY FL-bisindolylmaleimide, and SlowFade
antifade reagent were purchased from Molecular Probes, Inc.
(Eugene, OR, USA). Mouse monoclonal anti-rat PKC-b and -
IgG were purchased from Transduction Laboratories (Lexington,
KY, USA). FITC-conjugated goat anti-mouse igG was purchased
from Jackson ImmunoResearch Laboratories, Inc. (West Grove,
PA, USA). Tolrestat was a generous gift from Wyeth-Ayerst
Laboratories (Princeton, NJ, USA).
Mesangial cell culture
Mesangial cells were originally cultured from collagenase-
digested glomeruli isolated by graded sieving from the renal
cortex of 150 to 200 g male Sprague-Dawley rats. Mesangial cells
were characterized as previously described [26]. In brief, they
were spindle-shaped in appearance and contracted in response to
angiotensin II and arginine vasopressin. The cells demonstrated
immunocytochemical staining for desmin and vimentin, but not
for cytokeratin or factor VIII. Cultures were maintained in
DMEM supplemented with penicillin and streptomycin and FBS
10% at 37°C with CO2 5% and high humidity. Cell passages 5 to
10 were used in the present study. Mesangial cells grown in the
culture dishes were trypsinized, then transferred to glass cover-
slips (22 mm diameter) in 6-well culture plates and incubated in
normal glucose (5.6 mM) medium. At the desired subconfluence,
FBS was reduced to 0.5% to render the cells quiescent over 48
hours. The cells were incubated for 48 hours in glucose 5.6 mi, 15
mM, 30 m, or glucose 5.6 m plus mannitol 24.4 mM (as 30 mM
osmotic control), with or without Tolrestat 0.3 m. To furthur
investigate the mechanism of PKC action, phorbol 12-myristate
13-acetate (PMA), 0.1 M (Calbiochem, San Diego, CA, USA)
was added for 15 minutes (acute PKC activation) to stimulate
DAG-sensitive PKC, or for 24 hours to down-regulate DAG-
sensitive PKC.
Dual fluorescence labeling of F- and G-actin
Mesangial cells cultured on glass coverslips in the different
conditioned media described above were labeled simultaneously
with fluorescence probes according to our previously published
methods [81. Rhodamine-phalloidin and FITC-DNase-1 are spe-
cific for F- and G-actin, respectively [271. Briefly, the cells were
washed three times with phosphate buffered saline (PBS) and
were fixed in formaldehyde 3.7% in PBS for 15 minutes at room
temperature and permeabilized with Triton X-100 0.1% for 10
minutes. After washing three times with PBS, the cells were
incubated simultaneously with 200 l of rhodamine-phalloidin
0.165 LM and FITC-DNase-1 0.3 LM for 20 minutes in the dark.
The coverslips were mounted on glass slides with Aqua-Poly-
mount (Polysciences, Inc., Warrington, PA, USA) and SlowFade
antifade reagent. The specificity of fluorescence labeling was
determined with the following controls as previously reported [8]:
(1) measurement of unlabeled cell autofluorescence; (2) evalua-
tion of the nonspecificity of FITC-DNase-1 labeling by exposing
cells to unconjugated FITC alone in equal molar concentration to
that used for FITC-DNase-1 labeling; (3) measurement of specific
FITC-DNase-1 labeling by preincubation with DNase-1 1.2 LM,
followed by FITC-DNase-1 0.3 (4) examination of the
specificity of rhodamine-phalloidin labeling by preincubation of
cells with phalloidin 0.66 /LM alone followed by rhodamine-
phalloidin 0.165 LM [8].
Fluorescence labeling of total PKC
Mesangial cells cultured on glass coverslips in the different
conditioned media described above were labeled with BODIPY
FL-bisindolylmaleimide, which binds to the catalytic site on most
PKC isoforms [28]. Briefly, the cells were washed three times with
PBS and then fixed in formaldehyde 3.7% for 15 minutes at RT,
followed by permeabilization with 100% methanol at —20°C for
10 minutes. After washing three times with PBS, the cells were
>-. .•, .,,,
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Fig. 1. Dual-channel confocal microscopy images of growth-arrested mesangial cells are illustrated. Upper panels represent F-actin labeled with
rhodamine-phalloidin and the lower panels represent G-actin labeled with FITC-DNase-1 in the same cells. Cells were cultured in 0.5% FBS for 48
hours in the following conditions: A. glucose 5.6 mM; B. glucose 30 mrvi plus PMA 0.1 /.LM for the latter 24 hours; C. glucose 15 mM; D. glucose 30 mM
plus Tolrestat; E. glucose 30 mM; F. glucose 5.6 mi plus PMA 0.1 jIM for 15 minutes (Magnification X480).
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Table 1. Mesangial cell F- and G-actin labeled with rhodamine-
phalloidin and FITC-DNase-1, respectively, and analyzed by dual-
channel confocal microscopy
Group N
F-actin G-actin F/G-actin
average pixel intensity/cell
Glucose 5.6 m'vi (NG)
NG + Tolrestat
NG + PMA (24 hr)
Glucose 15 mrvi (MG)
MG + Tolrestat
Glucose 30 ma (HG)
HG + Tolrestat
HG + PMA (24 hr)
Mannitol (24.4 mM)
50
40
20
40
45
50
50
20
25
183 4
180 3
175 6
167 3°
173 3
155 4a,b
175 3°°
168 4"
177 4°
61 358 252 4
71 2°
62 2"°85 3"
62 2°°
58 5°"
59 3°
3.18 0.10
3.17 0.06
3.51 0.18
2.44 0.09°
2.86 007h
1.93 007°"
2.84 0.07'
3.20 0.20","
3.12 0.13°
Data are mean SEM.
ap < 0.01 vs. NG
"p < 0.01 vs. MG
P < 0.01 vs. HG
"P < 0.05 vs. HG
Not significant vs. NG
incubated with 200 j.d BODIPY FL-bisindolylmaleimide 10 I.tM in
PBS at RT for 20 minutes in the dark. The cells were washed three
times with PBS, and then mounted on glass slides as described
above. The specificity of fluorescence labeling was determined
with the following controls: (1) measurement of unlabeled cell
autofluorescence; (2) incubating the cells with unconjugated
BODIPY FL 10 /.tM alone; (3) preincubating the cells with
unconjugated bisindolylmaleimide 20 ,ILM for 20 minutes followed
by BODYPY FL-bisindolylmaleimide 10 jIM.
Immunofluorecence labeling of PKC isoforms
The cells on coverslips were fixed with formaldehyde 3.7% for
15 minutes at RT followed by membrane permeabilization with
100% methanol at —20°C for 10 minutes. After washing three
times with PBS, the cells were blocked with goat serum 1% plus
BSA 0.1% in PBS for 60 minutes at RT. Mouse monoclonal
anti-PKC isoform-b, or - antibodies were diluted to 1:100 in
blocking solution, and 200 jiA were added to each coverslip and
incubated at 37°C for 60 minutes. After washing three times with
PBS, the secondary antibody FITC-conjugated goat anti-mouse
IgG was diluted to 1:160 in blocking solution, and 200 pJ were
added to each coverslip. The cells were incubated at 37°C for 60
minutes in the dark, then washed three times with PBS and
mounted on glass slides as described above. The following con-
trols were performed: (1) incubation with FITC-conjugated goat
anti-mouse secondary antibody alone; (2) preincubation of the
cells with normal mouse IgG instead of primary PKC antibody,
followed by incubation with FITC-conjugated goat anti-mouse
IgG.
Confocal laser scanning microscopy
The fluorescence intensities and spatial distrubution configura-
tions of F- and G-actin, total PKC, PKC-8 and PKC- were
imaged using a confocal laser scanning image system (LSM 410,
Zeiss, Germany) with dual channel excitation and emission wave-
lengths: FITC (excitation 488 nm, emission 520 nm); BODIPY FL
(excitation 488 nm, emission 520 nm); rhodamine (excitation 514
nm, emission 580 nm). The argon ion laser beams were focused by
an oil-immersion inverted objective lens (Axiovert 100, X63) and
the image pixel resolution was 512 X 512 with a gray level scope
Fig. 2. Planar surface area of mesangial cells imaged by confocal micros-
copy labeled as described in Figure 1, measured by perimetiy. Growth-
arrested cells were cultured for 48 hours in glucose 5.6 mM (NG), glucose
15 mM (MG), glucose 30 mi (HG) with or without Toirestat (Tol), or
mannitol 24.4 m (Mann) plus glucose 5.6 mM. The sample number for
each group is identical to Table 1. Mean SEM are presented. up < 0.01
versus NG, "P < 0.05 versus NG, cp < 0.01 versus HG, "p < 0.01 versus
MG.
of 0 (minimum) to 255 (maximum) intensity. A section through
the maximum diameter (approximately the midpoint) in each cell
was digitized and outlined as a region of interest. The average
pixel intensity and planar area per cell were measured using a
LSM-IBM compatible DOS 5.0 software program. The average
absolute fluorescence intensities of the labeling F- and G-actin (in
the same cells), total PKC and PKC-b were analyzed for 20 to 60
cells/experimental group. Data were pooled from four to five
consecutive experiments. To standardize the fluorescence inten-
sity measurement among experiments, the confocal image con-
trast and brightness levels were adjusted optimally at the begin-
ning, and then kept constant through all experiments. Also, the
pinhole (size = 20), scanning time (0.546 seconds), zoom (= 1),
and magnification (63 x 1.4) of the confocal scanning system were
identical throughout all experiments. The digitized confocal im-
ages were obtained from a video printer connected to the confocal
laser scanning system using the image processing software.
Measurement of PKC activity by 32P-phosphoiylation of
EGF-receptor substrate
PKC activity was measured in situ using digitonin-permeabi-
lized mesangial cells and the PKC-specific EGF receptor peptide
substrate VRKRTLRRL, as described by Williams and Schrier
[29, 30]. Mesangial cells were seeded onto 96-well microtiter
plates at a density of 20,000 cells/well and cultured in FBS 10% for
three to four days until confluent. Then, cells were growth-
arrested in FBS 0.5% and cultured in glucose 5.6 mM or 30 m for
48 hours. To test shorter time exposures in high glucose, cells were
growth-arrested, placed in glucose 5.6 m and then the medium
was changed to glucose 30 m for 1, 6 or 24 hours prior to the
assay. PMA 0.1 jIM was added for 15 minutes or 24 hours prior to
assay to either stimulate or down-regulate, respectively, PKC
activity. The test medium was then aspirated and replaced with 40
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Fig. 3. Confocal microscopy images of mesangial cells where total protein kinase C is labeled with BODIPYFL-bisindolylmaleimide. Growth-arrested cells
were cultured for 48 hours in the following conditions: (A) glucose 5.6 mM; (B) glucose 30 mrvi plus PMA 0.1 gi for the latter 24 hours; (C) glucose
15 mM; (D) glucose 30 mt plus Toirestat; (E) glucose 30 mi, (F) glucose 5.6 mi plus PMA 0.1 iM for 15 minutes (magnification X480).
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Table 2. Mesangial cell total PKC labeled with BODIPY FL-
bisindolylmaleimide and analyzed by confocal fluorescence microscopy
Group (N = 40)
Total PKC
average pixel intensilylcell
Glucose 5.6 mi (NG) 84 2
NG + Tolrestat 84 3
NG+PMA24hr 85±3
Glucose 15 mM (MG) 103 2
MG + Tolrestat 102 4
Glucose 30 mi (HG) 156 2a,b
HG + Toirestat 105 2°
HG + PMA 24 hr 90 3°
a P < 0.01 vs. NG
hP < 0.01 vs. MG
°P < 0.01 vs. HG
d Not significant vs. NG
jLl of reaction buffer containing: glucose 5.6 or 30 mi, NaCI 137
mM, KC1 5.4 mrvi, MgCI2 10 m'vi, Na2PO4 0.3 mi, K2P04 0.4 mM,
f3-glycerolphosphate 25 mi, EGTA 5 mrvi, CaCl2 1 mrvi, Hepes 20
mM, [y32-PJATP (1000 cpm/pmol; Amersham, Arlington Hts., IL,
USA) 100 I.LM, digitonin 50 g/ml and VRKRTLRRL 100 /.tM.
The reaction proceeded for 10 minutes at 30°C before termination
with 50 jLl of TCA 9% at 4°C. Aliquots of 45 jil of the
TCA-precipitated mixture were spotted onto 2.1 cm P-81 phos-
phocellulose disks (Whatman Inc., Clifton, NJ, USA) and washed
three times (2 mm/wash) with 75 m phosphoric acid and once
with Na2PO4 75 mrvt, pH 7.5. Background phosphorylation was
assessed by performing the assay in the absence of peptide
substrate. Samples were counted in Redi-Protein scintillation
liquid (Beckman Instruments Inc., Fullerton, CA, USA). Each
time point was measured in quadruplicate and the experiment was
repeated five times. PKC-dependent phosphorylation was ex-
pressed as pmol/min/mg cellular protein.
Immunoblotting of PKC-8
Mesangial cells were cultured to confluence in 60 mm diameter
dishes and then growth-arrested in FBS 0.5% and placed in
glucose 5.6 m or 30 mi, with or without Tolrestat 0.3 m, for 48
hours. The cells were washed twice with PBS, scraped in 300 jLJ
lysis buffer containing NaHCO3 1 mivi, MgC12 6HO 5 mM,
Tris-HCI 50 mii, EGTA 10 mi, EDTA 2 mi, leupeptin 25 gIml,
2-13-mercaptoethanol 1%, phenylmethylsulfonyl fluoride 0.6 mtvi,
Triton-X-100 1%, and sodium dodecyl sulfate 1%. DNA was
removed with a DNA filter (SQ-Easy Filters; Porex Technologies,
Fairburn, GA, USA). The protein concentration was determined
by the Bradford method (Bio-Rad Laboratories, Mississauga, ON,
Canada) and 50 jtg of total cell protein were loaded onto an
Immobilon PVDF membrane (Millipore, Bedford, MA, USA) for
two hours at 250 mA using a Bio-Rad Transblot apparatus. The
membrane was blocked for two hours in blocking buffer (5%
non-fat dry milk powder, BSA 5%, Tris HC1 10 mM, NaCl 150 mM,
and Tween-20 0.05% vol/vol) at RT. The membrane was then
incubated with monoclonal PKC-b antibody 0.5 tg/ml in incuba-
tion buffer without BSA. The last incubation was performed with
horseradish peroxidase-conjugated goat anti-mouse IgG, diluted
1:5000 (Bio/Can Scientific). The membranes were thoroughly
washed after each incubation with Tris-HCI 10 ms, NaCl 150 mM,
and Tween-20 0.05% and the final wash was in the absence of
detergent. A chemiluminescence kit (Canadian life Technologies,
Burlington, Ontario, Canada) and Kodak X-Omat AR film (East-
man Kodak, Rochester, NY, USA) were used for development.
The PKC-5 was identified using molecular weight markers and a
positive control (Bio/Can Scientific). To determine the density,
the photograph was digitized and the area of each specific band
was calculated using JAVA (Jandel Scientific, San Rafael, CA,
USA) software and multiplied by its mean pixel intensity (grey
scale 1 to 255) to obtain total density. Background intensity was
subtracted from each band.
Statistical analysis
Statistical analyses were performed using ANOVA unless oth-
erwise indicated. Results are expressed as mean SEM.
Results
Mesangial cell F- and G-actin content and planar area analyzed
by confocal microscopy
Mesangial cells on coverslip assumed a flattened, almost two-
dimensional appearance with a height of approximately 2 tm. A
confocal image of 0.4 urn width at the maximal cell diameter and
through the cell nucleus was digitized for each cell. As previously
reported [8], mesangial cells under all experimental conditions
displayed no measureable autofluorescence. Non-specific labeling
with either rhodamine or FITC alone was not significant. Prein-
cubation of the cells with either phalloidin or DNase-1 resulted in
minimal labeling with subsequent rhodamine-phalloidin or FITC-
DNase-1.
Figure 1 illustrates the dual-channel images where rhodamine-
phalloidin (upper panels) and FITC-DNase-1 (lower panels) were
observed simultaneously. Figure 1A represents a mesangial cell
cultured in glucose 5.6 m. The F-actin (upper panel) filled the
cytoplasm and was organized in a bundled pattern. G-actin (lower
panel) was distributed throughout the cytoplasm. Figure lB
represents mesangial cells cultured in glucose 30 m for 48 hours
plus PMA 0.1 M for the latter 24 hours. The F- and G-actin
patterns resemble those observed in glucose 5.6 m. Figure 1C
and Figure 1E illustrate mesangial cells cultured in glucose 15 mi
and 30 m, respectively, where the most striking change was a
progressive increase in G-actin. Figure 1D represents mesangial
cells cultured in glucose 30 m plus Tolrestat which prevented
high glucose-induced G-actin accumulation. Figure IF illustrates
mesangial cells cultured in glucose 5.6 m exposed for 15 minutes
to PMA 0.1 jLM where a decrease in F-actin and increase in
G-actin intensity was observed resembling the pattern in glucose
30 mM (Fig. 1E). The cell height, as determined by serial
sectioning with the confocal laser beam, remained constant (ap-
proximately 2 Lm) in 5, 15 and 30 m glucose, with or without
Tolrestat.
In Table 1, the average pixel intensity/cell for F-actin (rhodam-
ine-phalloidin) and G-actin (FITC-DNase-1) measured simulta-
neously in each cell using dual-channel confocal microscopy are
compared. The F-/G-actin ratio was calculated for each cell and
the mean SEM is reported for each group. A progressive
decrease of F-actin and increase of G-actin intensities were
observed in glucose 15 m and 30 m compared to the pattern in
glucose 5.6 m. This change in actin pattern was reflected also in
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Table 3. Mesangial cell protein kinase C (PKC) activity measured in
Situ by 32P-phosphorylation of the EGF-receptor substrate
Group
PKC activity (pmol/min/mg)
exposure to high glucose time hours
0 1 3 6 24 48
Glucose30mM 27±3 25±2 25±1 33±5 32±1 28±1
(N =5)
Glucose 30 mM 93 4 105 4 100 4 93 4 94 2 102 I
+ PMAO.1 uM
(15 mm)
(N =5)
the F-/G-actin ratios which similarly declined in glucose 15 mM
and 30 m compared to glucose 5.6 mivi. Tolrestat did not affect
the F- or G-actin content in glucose 5.6 mrvi. Tolrestat significantly
reversed the effects of glucose 15 m and 30 mM on F- and
G-actin content and the F-/G-actin ratio. Similarly, PMA expo-
sure for 24 hours in glucose 30 m prevented the effects of high
glucose on F- and G-actin content and completely normalized the
F-/G-actin ratio. Mannitol had no effect on the F- or G-actin
contents or the F-/G-actin ratio.
Mesangial cell planar area measured by perimetry are pre-
sented in Figure 2. A progressive decline in cell size was observed
in 15 m and 30 m glucose compared to the 5.6 m glucose
condition. Tolrestat significantly prevented the change in cell size
in both 15 m and 30 mrvi glucose. Mannitol had no effect on
planar area.
Mesangial cell total PKC analyzed by fluorescence confocal
microscopy
The specificity of the fluorescence probe BODIPY FL-bisin-
dolylmaleimide was examined by first determining that negligible
labeling of the cells occurred with BODIPY FL alone. Second,
preincubation with bisindolylmaleimide prevented significant la-
beling with BIODIPY FL-bisindolylmaleimide later. Third, a
significant change in distribution pattern was observed in the
presence of acute stimulation with PMA described below, sug-
gesting that DAG-sensitive PKC isoforms were labeled with this
probe.
Figure 3 illustrates the patterns of total PKC observed with
BODIPY FL-bisindolylmaleimide. Figure 3A represents mesan-
gial cells cultured in glucose 5.6 m where PKC was located in the
cytosol, with minimal nuclear labeling. Figure 3B illustrates cells
cultured in glucose 30 m for 48 hours plus PMA 0.1 jxM for the
latter 24 hours where the pattern and fluorescence intensity
appeared similar to the normal glucose condition in Figure IA.
Figure 3 C and E represent cells cultured in glucose 15 m and 30
m, respectively, where a progressive increase in total fluores-
cence intensity and perinuclear distribution of PKC labeling were
observed. Figure 3D illustrates cells cultured in glucose 30 mM
plus Tolrestat where the PKC pattern appeared partially reversed.
Figure 3F shows cells in glucose 5.6 m that were stimulated for
15 minutes with PMA 0.1 j.M. PKC redistribution to a perinuclear
and nuclear pattern was observed. This pattern is similar to that
observed in 30 ms (Fig. 3E). Acute activation of DAG-sensitive
PKC with PMA (Fig. 3F) resulted in increased fluorescence
intensity perhaps due to increased PKC affinity to BODIPY
FL-bisindolylmaleimide that binds to the pseudosubstrate site.
In Table 2 the average pixel intensity/cell of BODIPY FL-
Table 4. Mesangial cell PKC-b analyzed by immunofluorescence
confocal microscopy
Group N
PKC
average pixel intensity/cell
Glucose 5.6 msj (NG) 40 83 4
NG + Tolrestat 20 91 4
NG + PMA (10 mm) 40 141 3
Glucose 15 msi (MG) 40 102
MG + Tolrestat 40 100 3
Glucose 30 mvi (HG) 60 143 3"'
HG + Tolrestat 40 115 2C
HG + PMA (24 hr) 40 89 2C
ap < 0.01 vs. NG
bp < 0.01 vs. MG
P < 0.01 vs. HG
bisindolylmaleimide is compared across experimental groups. In
glucose 5.6 m, neither Tolrestat, nor 24 hours of exposure to
PMA 0.1 /LM altered the total PKC labeling intensity. A progres-
sive and significant increase in fluorescence intensity was observed
in glucose 15 m and 30 m compared to that in glucose 5.6 mivi.
Tolrestat had no effect on the moderate increase in fluorescence
intensity observed in glucose 15 m. In glucose 30 mrvi, Tolrestat
caused a significant decrease in total PKC fluorescence intensity
that appeared similar to the glucose 15 m condition. In glucose
30 mM, 24 hours of exposure to PMA 0.1 LM completely pre-
vented the change in fluorescence intensity of the PKC.
Measurement of PKC activity
Table 3 shows that basal PKC activity measured by 32P-
phosphorylation of the EGF receptor peptide substrate was not
increased significantly between 1 and 48 hours of exposure to
glucose 30 m (compared to 0 hr). Background phosphorylation
was < 0.05% of total added cpm. PMA-stimulated PKC activity
increased three to four times above unstimulated conditions (P <
0.01). Following PMA incubation for 24 hours, the PKC activity
was negligible (< 5 pmol/mmn/mg).
Mesangial cell PKC-b and PKC- immunofluorescence imaging
The specificity of the immunofluorescence labeling was first
analyzed by determining that the F1TC-goat anti-mouse second-
ary antibody alone did not bind to the cells. Preincubation of the
cells with normal mouse IgG instead of primary PKC antibody
followed by the FITC-goat anti-mouse secondary antibody did not
significantly label the cells.
Figure 4 illustrates the labeling of mesangial cells with anti-
PKC-8. In Figure 4A, representative cells cultured in glucose 5.6
mM are shown where PKC-b was distributed in cytosol and
perinuclear regions. Figure 4B demonstrates cells cultured in
glucose 30 m for 48 hours with 24 hours exposure to PMA 0.1
fLM where the PKC-b pattern appeared similar to that in glucose
5.6 m. Figure 4 C and E illustrate the progressive increase in
PKC-I3 observed in glucose 15 m and 30 ms, respectively. In high
glucose, PKC-b was increased and distributed in a cytoskeleta!
pattern. Figure 4D illustrates cells cultured in glucose 30 m plus
Tolrestat where the PKC-b intensity and pattern were similar to
that observed in glucose 15 m, which may represent partial
reversal of the higher glucose effect observed in Figure 4E. In
Figure 4F, cells cultured in glucose 5.6 m were exposed for 15
minutes to PMA 0.1 LM where PKC-b was redistributed to the
Fig. 4. Confocal microscopy images of mesangial cells where protein kinase C-b is labeled with a primaiy monoclonal antibody visualized by a secondaiy
FJTC-antihody. Growth-arrested cells were cultured for 48 hours in the following conditions: (A) glucose 5.6 mM; (B) glucose 30 mM plus PMA 0.1 /LM
for the latter 24 hours; (C) glucose 15 mM; (D) glucose 30 m plus Toirestat; (E) glucose 30 mM; (F) glucose 5.6 m plus PMA 0.1 LM for 15 minutes
(magnification x480).
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Fig. 5. Immunoblot of total lysate of mesangial
cells growth-arrested and cultured for 48 hours in
glucose 5.6 mw (NG), 30 mM (HG) or 30 mM
plus Toirestat (To!). PKC-8 specific monoclonal
primary antibody revealed a single band of 78
kDa. The same primary antibody was also used
for confocal imaging. Results from two separate
and representative experiments for each
condition are shown.
plasma membrane, perinuclear and nuclear areas compared to
Figure 4A. The pattern is dissimilar to that observed in glucose 15
and 30 m, suggesting that the images in Figure 4 C and E
presented an accumulation of PKC-.
In Table 4, the average pixel intensity/cell of PKC-b immuno-
fluorescence is reported for each experimental group. In normal
glucose, acute stimulation with PMA caused a significant increase
in pixel intensity parallel to redistribution of the fluorescence
probe to the perinuclear and nuclear area observed in Figure 4F.
A progressive increase in intensity was observed in glucose 15 mivi
and 30 m compared to the glucose 5.6 m condition. Although
Tolrestat had no effect on the increased intensity of PKC-6
labeling in glucose 15 mtvi, partial inhibition of PKC-b accumula-
tion in glucose 30 m was observed. In glucose 30 mlvi, 24 hours
exposure to PMA 0.1 /tM completely inhibited the increase in
PKC-6 fluorescence intensity.
Immunoblot analysis of total cellular PKC-b after 48 hours
exposure to glucose 5.6 mad, 30 m or 30 m plus Tolrestat
indicates a substantial increase of PKC-h in high glucose which is
prevented by Tolrestat. Figure 5 illustrates the representantive
bands in glucose 5.6 mtvt, 30 m and 30 m plus Tolrestat, each
from separate sample cell lysates. Each experimental condition
was repeated 5 times and densitometry revealed 27 8% increase
of PKC-5 in glucose 30 mM compared to 5.6 mM. Tolrestat
reduced the densitometry value to normal levels (P < 0.05,
glucose 30 ifiM vs. glucose 30 m plus Tolrestat, Tukey test).
Figure 6 illustrates the labeling of cells with anti-PKC-. Figure
6A shows cells in glucose 5.6 m where the PKC- pattern was
cytosolic and likely associated with the cytoskeleton. In glucose 30
mM (Fig. 6B), no significant change in fluorescence intensity and
distribution pattern was observed. In glucose 5.6 m, stimulation
with PMA for 15 minutes (Fig. 6C) caused no change in PKC-
fluorescence pattern or intensity. Figure 6D illustrates that in
glucose 30 msi, Tolrestat had no effect on the fluorescence pattern
or intensity.
Discussion
The results of this study indicate that high glucose causes
mesangial cell F-actin disassembly through a PKC-dependent
pathway. The effect of high glucose on mesangial cell F-actin
assembly requires 48 hours [81. Down-regulation of DAG-sensi-
tive PKC isoforms, including PKC- with 24 hours of exposure to
PMA completely prevented F-actin disassembly and depolymer-
ization (Table 1 and Fig. 1) in high glucose. In glucose 15 m and
30 m for 48 hours, incremental accumulation and cellular
redistribution of total PKC and PKC-b, but not PKC- were
observed (Figs. 3, 4 and 6). In high glucose, PMA down-regulation
of PKC was associated with normalization of the fluorescence
patterns of both total PKC and PKC-b. Following PMA exposure
for 15 minutes in glucose 5.6 m, the redistribution of total PKC
(Fig. 3F) and PKC-b (Fig. 4F) included translocation from the
cytosol to perinuclear and nuclear region, and for PKC-b, to a
lesser extent to the plasma membrane. PKC activity, measured by
phosphorylation of the EGF-receptor substrate, increased three
to four times during acute activation with PMA. Exposure to
PMA for 24 hours was very effective in abolishing basal PKC
activity. This assay did not detect a significant change in basal
PKC activity during high glucose exposure up to 48 hours.
However, the exact PKC-isoform specificity and sensitivity of the
EGF-receptor substrate assay is unclear. Our confocal imaging
data suggested that accumulation of some DAG-sensitive iso-
forms including PKC-, but not the DAG-insensitive PKC-,
occurred in a glucose concentration-dependent manner over 48
hours. The observation that down-regulation of PKC with PMA
over the latter 24 hours in high glucose normalizes the F- and
G-actin content and assembly pattern, suggests that accumulation
and likely activation of some DAG-sensitive PKC isoforms within
the 48 hours period of exposure to high glucose, not identified
with the EGF-receptor substrate assay, are necessary for altered
F-actin assembly.
These data differ from previous reports of Ayo et al [1] and
Williams and Schrier [30], who reported an early increase in
mesangial cell PKC activity within one to three hours following
exposure to high glucose. The preparation of mesangial cells in
our study varies from these previous reports in that our cells are
growth-arrested and studied between the 5th to 10th passages.
Mesangial cells exposed to high concentrations of fetal bovine
serum are cycling and therefore may exhibit different expression
and activation patterms of PKC isoforms.
Tolrestat significantly inhibited F-actin disassembly and reduc-
tion in cell size observed in high glucose (Table 1 and Fig. 2).
Increases in total PKC (Fig. 3 and Table 2) and PKC- (Fig. 4 and
Table 4) in high glucose measured by fluorescence intensities were
significantly reduced in the presence of Tolrestat. These data
indicate a likely cause-and-effect relationship between activation
of the polyol pathway and PKC-mediated F-actin disassembly in
high glucose. A partial inhibition of PKC- accumulation in
glucose 30 m was observed in the presence of Toirestat (Table
4), suggesting that the accumulation and/or activation of some
PKC isoforms may be regulated by more than one mechanism
NG HG HG+ToL
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Fig. 6. Confocal microscopy images of mesangial cells where protein kinase C- is labeled with a primary monoclonal antibody visualized by a secondary
FITC-antibody. Growth-arrested cells were cultured for 48 hours in the following conditions: (A) glucose 5.6 mM; (B) glucose 30 mM; (C) glucose 5.6
m plus PMA 0.1 zri for 15 minutes; (D) glucose 30 mM plus Tolrestat (magnification X480).
including activation of the polyol pathway. Neither high glucose
nor Toirestat altered the fluorescence intensity or distribution of
PKC- (Fig. 6). These data are in keeping with a selective effect of
high glucose on some DAG-sensitive, but not DAG-insensitive
PKC isoforms.
The imaging data cannot accurately distinguish between PKC
accumulation and activation. The immunoblot analysis (Fig. 5)
confirmed the increased total cellular PKC-8 after 48 hours of
high glucose, prevented by Tolrestat, suggesting that the increased
fluorescence intensity of PKC-b in high glucose is due, at least in
part, to accumulation of this isoform. The relationships among
high glucose, polyol pathway activation, activation and accumula-
tion of specific PKC isoforms are complex and require detailed
examination of each PKC isoform in high glucose.
In vivo, mesangial cells attach to the glomerular basement
membrane tethering the capillary loops which sustain massive
filtration of plasma water driven by hydrostatic pressure. Similar
to vascular smooth muscle cells, mesangial cells contain filament
bundles composed of F-actin, myosin and a-actinin, which are
postulated to create isometric tension or small isotonic contrac-
tions to counteract the distending force of intracapillary hydro-
static pressure [111. These arrays of filaments are found in the
subendothelial mesangial cell processes that attach to the glomer-
ular basement membrane, and isometric contraction at these sites
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may alter the ultrafiltration properties of the capillary loops [12,
311. Although mesangial cells cultured on a two-dimensional
surface assume a flattened phenotype, they continue to form
cytoskeletal filament bundles composed of myosin and F-actin.
The signaling and contractile responses of cultured cells to
vasopressor peptides are similar to these specific functions ob-
served in vivo [32]. The normal contractile response to vasopres-
sor peptides includes both myosin light chain phosphorylation [33]
and F-actin partial disassembly [8—10]. Acute activation of PKC
with a phorbol ester causes F-actin disassembly in mesangial cells
(Fig. iF) [8] and nonmuscle cells, such as pituitary [34] and
corneal endothelial [35] cells. Phosphorylation of a number of
cytoskeleton-associated proteins may be involved in PKC-medi-
ated F-actin disassembly, including MARCKS, which causes
debinding of F-actin from plasma membrane integrin attachment
complexes [36]. Mesangial cells cultured in high glucose display
F-actin partial disassembly [8], decrease in cell size (Fig. 2) and
loss of normal contractile responsiveness to vasopressor stimuli
[13]. Recently, we reported that treatment of hyperglycemic STZ
rats with Tolrestat preserved the normal contractile response of
mesangial cells to endothelin-1, prevented glomerular hyperfiltra-
tion, normalized microalbuminuria and inhibited the glomerular
growth response to the diabetic milieu [23]. The present study
links glucose metabolism through the polyol pathway as an
effector mechanism for F-actin disassembly mediated by PKC.
The results of this study may have broader implications for the
relevance of the polyol pathway as an effector mechanism in high
glucose-induced PKC signaling. Recent data support the role of
PKC in the mediation of events, such as TGF-/3 stimulation of
collagen IV gene expression, leading to the pathogenesis of early
progressive diabetic glomerulopathy [37]. Further exploration of
the prevention of polyol pathway-mediated activation of PKC,
particularly the growth response and extracellular matrix accumu-
lation, will be important in the clinical application of aldose
reductase inhibitors for treatment of diabetic nephropathy.
In conclusion, this study demonstrates that F-actin diassembly
in mesangial cells is PKC-mediated and is significantly dependent
on activity of the polyol pathway. DAG-sensitive PKC-b and
DAG-insensitive PKC- are abundantly expressed in quiescent
mesangial cells. In high glucose, the accumulation and redistribu-
tion of total PKC and PKC-b are partially reversed with Tolrestat,
suggesting that the polyol pathway is also involved.
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